Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
9.72
+0.96 (10.96%)
At close: Nov 4, 2026, 4:00 PM EST
9.72
0.00 (0.00%)
After-hours: Nov 4, 2026, 4:10 PM EST
Orthofix Medical Revenue
Orthofix Medical had revenue of $210.93M in the quarter ending June 30, 2026, with 3.85% growth. This brings the company's total for the last twelve months to $833.19M, up 2.99% year-over-year. In the year 2025, Orthofix Medical had annual revenue of $822.31M with 2.85% growth. That makes Orthofix Medical the 8,514th largest company in the world by revenue and 1,916th in the United States.
Revenue (ttm)
$833.19M
Revenue Growth
+2.99%
P/S Ratio
0.48
Revenue / Employee
$519,119
Employees
1,605
Market Cap
395.92M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Orthofix Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 822.31M | 22.82M | 2.85% |
| Dec 31, 2024 | 799.49M | 52.85M | 7.08% |
| Dec 31, 2023 | 746.64M | 285.93M | 62.06% |
| Dec 31, 2022 | 460.71M | -3.77M | -0.81% |
| Dec 31, 2021 | 464.48M | 57.92M | 14.25% |
| Dec 31, 2020 | 406.56M | -53.39M | -11.61% |
| Dec 31, 2019 | 459.96M | 6.91M | 1.53% |
| Dec 31, 2018 | 453.04M | 19.22M | 4.43% |
| Dec 31, 2017 | 433.82M | 24.04M | 5.87% |
| Dec 31, 2016 | 409.79M | 13.30M | 3.35% |
| Dec 31, 2015 | 396.49M | -5.79M | -1.44% |
| Dec 31, 2014 | 402.28M | 4.67M | 1.17% |
| Dec 31, 2013 | 397.61M | -42.58M | -9.67% |
| Dec 31, 2012 | 440.19M | 4.67M | 1.07% |
| Dec 31, 2011 | 435.52M | -27.05M | -5.85% |
| Dec 31, 2010 | 462.57M | -83.06M | -15.22% |
| Dec 31, 2009 | 545.64M | 25.96M | 5.00% |
| Dec 31, 2008 | 519.68M | 29.35M | 5.99% |
| Dec 31, 2007 | 490.32M | 124.96M | 34.20% |
| Dec 31, 2006 | 365.36M | 52.06M | 16.61% |
| Dec 31, 2005 | 313.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 301.61M |
| Cerus | 221.55M |
| Treace Medical Concepts | 205.31M |
| NeuroPace | 106.99M |
| 908 Devices | 60.84M |
| Shoulder Innovations | 60.06M |
| SS Innovations International | 52.40M |
| ClearPoint Neuro | 45.49M |
OFIX News
- 12 days ago - Orthofix to Report Third Quarter 2026 Financial Results - Business Wire
- 22 days ago - Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 2 months ago - Orthofix Medical Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 2 months ago - Orthofix price target lowered to $13 from $18 at Canaccord - TheFly
- 3 months ago - Orthofix price target lowered to $14 from $17 at Barrington - TheFly
- 3 months ago - Orthofix price target lowered to $13 from $15 at Stifel - TheFly
- 3 months ago - Orthofix Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Orthofix Medical Slides: Q2 2026 - Filings